Excelsior Biopharma Inc. (6496.TWO)

TWD 30.0

(0.0%)

EBITDA Summary of Excelsior Biopharma Inc.

  • Excelsior Biopharma Inc.'s latest annual EBITDA in 2023 was -29.36 Million TWD , down -3911.14% from previous year.
  • Excelsior Biopharma Inc.'s latest quarterly EBITDA in 2024 Q2 was 1.52 Million TWD , up 103.02% from previous quarter.
  • Excelsior Biopharma Inc. reported an annual EBITDA of 4.41 Million TWD in 2022, down -97.3% from previous year.
  • Excelsior Biopharma Inc. reported an annual EBITDA of 23.15 Million TWD in 2021, down -62.74% from previous year.
  • Excelsior Biopharma Inc. reported a quarterly EBITDA of -14.71 Million TWD for 2024 Q1, down -150.4% from previous quarter.
  • Excelsior Biopharma Inc. reported a quarterly EBITDA of 27.82 Million TWD for 2023 Q4, up 284.5% from previous quarter.

Annual EBITDA Chart of Excelsior Biopharma Inc. (2023 - 2019)

Historical Annual EBITDA of Excelsior Biopharma Inc. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 -29.36 Million TWD -3911.14%
2022 4.41 Million TWD -97.3%
2021 23.15 Million TWD -62.74%
2020 74.14 Million TWD -29.59%
2019 105.3 Million TWD 0.0%

Peer EBITDA Comparison of Excelsior Biopharma Inc.

Name EBITDA EBITDA Difference
Allied Biotech Corporation 204.79 Million TWD 114.341%
GeneFerm Biotechnology Co., Ltd. 231.09 Million TWD 112.709%
Easywell Biomedicals, Inc. -85.5 Million TWD 65.651%
TTY Biopharm Company Limited 1.52 Billion TWD 101.927%
Synmosa Biopharma Corporation 1 Billion TWD 102.911%
Orient EuroPharma Co., Ltd. 582.93 Million TWD 105.038%
Center Laboratories, Inc. -175.17 Million TWD 83.234%
Tien Liang BioTech Co., Ltd. 31.04 Million TWD 194.592%
Orient Pharma Co., Ltd. 172.39 Million TWD 117.036%
InnoPharmax Inc. -62.12 Million TWD 52.722%
Johnson Chemical Pharmaceutical Works Co., Ltd. 126.67 Million TWD 123.184%
DV Biomed Co., Ltd. 407.64 Million TWD 107.205%
Foresee Pharmaceuticals Co., Ltd. -912.16 Million TWD 96.78%
Handa Pharmaceuticals, Inc. 802.78 Million TWD 103.658%
UniPharma Co., Ltd. -16.25 Million TWD -80.688%
Anxo Pharmaceutical Co., Ltd. 131.31 Million TWD 122.366%
Alar Pharmaceuticals Inc. 394.52 Million TWD 107.444%
Winston Medical Supply Co., Ltd. 228.32 Million TWD 112.863%
Mercury Biopharmaceutical Corporation -39.03 Million TWD 24.76%
Bioray Biotech Co., Ltd 12.13 Million TWD 342.019%
TSH Biopharm Corporation Limited 99.35 Million TWD 129.561%